Sector Chart BriaCell Therapeutics Corp. Nasdaq
Stocks
BCTX
CA1079303071
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.940 USD | +6.49% |
|
+6.49% | -44.59% |
| 07-07 | BriaCell Engages Consulting and Branding Firms to Support Potential Commercialization of Bria-IMT | MT |
| 06-25 | BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 34.19M | - | - | - | - | - |
| 57.82B | |||||
| 53.71B | |||||
| 23.8B | - | ||||
| 23.26B | - | ||||
| 20.7B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
